Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis.

Katragadda U, Fan W, Wang Y, Teng Q, Tan C.

PLoS One. 2013;8(3):e58619. doi: 10.1371/journal.pone.0058619. Epub 2013 Mar 7.

2.

Multi-drug delivery to tumor cells via micellar nanocarriers.

Katragadda U, Teng Q, Rayaprolu BM, Chandran T, Tan C.

Int J Pharm. 2011 Oct 31;419(1-2):281-6. doi: 10.1016/j.ijpharm.2011.07.033. Epub 2011 Jul 27.

3.

Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.

Shin HC, Cho H, Lai TC, Kozak KR, Kolesar JM, Kwon GS.

J Control Release. 2012 Oct 10;163(1):93-9. doi: 10.1016/j.jconrel.2012.04.024. Epub 2012 Apr 23.

4.

A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.

Xiong MP, Yáñez JA, Kwon GS, Davies NM, Forrest ML.

J Pharm Sci. 2009 Apr;98(4):1577-86. doi: 10.1002/jps.21509.

5.

Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.

Larson N, Greish K, Bauer H, Maeda H, Ghandehari H.

Int J Pharm. 2011 Nov 25;420(1):111-7. doi: 10.1016/j.ijpharm.2011.08.011. Epub 2011 Aug 12.

6.

Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).

Chandran T, Katragadda U, Teng Q, Tan C.

Int J Pharm. 2010 Jun 15;392(1-2):170-7. doi: 10.1016/j.ijpharm.2010.03.056. Epub 2010 Apr 2.

PMID:
20363305
7.

Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG.

Hasenstein JR, Shin HC, Kasmerchak K, Buehler D, Kwon GS, Kozak KR.

Mol Cancer Ther. 2012 Oct;11(10):2233-42. doi: 10.1158/1535-7163.MCT-11-0987. Epub 2012 Aug 14.

8.

Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.

Cho H, Kwon GS.

J Drug Target. 2014 Aug;22(7):669-77. doi: 10.3109/1061186X.2014.931406. Epub 2014 Jun 25.

9.

Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.

Pradhan R, Ramasamy T, Choi JY, Kim JH, Poudel BK, Tak JW, Nukolova N, Choi HG, Yong CS, Kim JO.

Carbohydr Polym. 2015 Jun 5;123:313-23. doi: 10.1016/j.carbpol.2015.01.064. Epub 2015 Feb 7.

PMID:
25843864
10.

Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.

Saxena V, Hussain MD.

Colloids Surf B Biointerfaces. 2013 Dec 1;112:350-5. doi: 10.1016/j.colsurfb.2013.07.031. Epub 2013 Aug 2.

PMID:
24012704
11.

Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery.

Fan W, Wang Y, Dai X, Shi L, Mckinley D, Tan C.

Pharm Res. 2015 Apr;32(4):1325-40. doi: 10.1007/s11095-014-1537-6. Epub 2014 Oct 16.

PMID:
25319102
12.

Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.

Shin DH, Kwon GS.

Int J Pharm. 2017 Feb 25;518(1-2):307-311. doi: 10.1016/j.ijpharm.2017.01.006. Epub 2017 Jan 3.

PMID:
28062368
13.
14.

Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel.

Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL, Sellers W, Rosen N, Solit DB.

Cancer Res. 2008 Jan 15;68(2):589-96. doi: 10.1158/0008-5472.CAN-07-1570.

15.

Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer.

Xiao W, Luo J, Jain T, Riggs JW, Tseng HP, Henderson PT, Cherry SR, Rowland D, Lam KS.

Int J Nanomedicine. 2012;7:1587-97. doi: 10.2147/IJN.S29306. Epub 2012 Mar 27.

16.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.

Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.

Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032. Epub 2014 May 22.

PMID:
24858391
17.

A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.

Ramalingam SS, Egorin MJ, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland DM, Stoller RG, Potter DM, Ivy SP, Belani CP.

Clin Cancer Res. 2008 Jun 1;14(11):3456-61. doi: 10.1158/1078-0432.CCR-07-5088.

18.

A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.

Shin HC, Alani AW, Cho H, Bae Y, Kolesar JM, Kwon GS.

Mol Pharm. 2011 Aug 1;8(4):1257-65. doi: 10.1021/mp2000549. Epub 2011 Jun 23.

19.

Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles.

Han Y, He Z, Schulz A, Bronich TK, Jordan R, Luxenhofer R, Kabanov AV.

Mol Pharm. 2012 Aug 6;9(8):2302-13. doi: 10.1021/mp300159u. Epub 2012 Jun 28.

20.

Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.

Nguyen DM, Lorang D, Chen GA, Stewart JH 4th, Tabibi E, Schrump DS.

Ann Thorac Surg. 2001 Aug;72(2):371-8; discussion 378-9.

PMID:
11515869

Supplemental Content

Support Center